Page last updated: 2024-08-18

4-butyrolactone and Acute Liver Injury, Drug-Induced

4-butyrolactone has been researched along with Acute Liver Injury, Drug-Induced in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abdallah, HM; Abdel-Naim, AB; Alamoudi, AJ; Eid, BG; Ibrahim, SRM; Kammoun, AK; Mohamed, GA; Shaik, RA; Sirwi, A1
Ho, HY; Hsieh, CC; Lin, WC; Lin, WL; Tsay, HS; Wu, JB1

Other Studies

2 other study(ies) available for 4-butyrolactone and Acute Liver Injury, Drug-Induced

ArticleYear
Mokko Lactone Attenuates Doxorubicin-Induced Hepatotoxicity in Rats: Emphasis on Sirt-1/FOXO1/NF-κB Axis.
    Nutrients, 2021, Nov-19, Volume: 13, Issue:11

    Topics: 4-Butyrolactone; Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Doxorubicin; Glutathione; Liver; Malondialdehyde; Nerve Tissue Proteins; NF-kappa B; Rats; Sesquiterpenes; Signal Transduction; Sirtuin 1; Superoxide Dismutase

2021
The hepatoprotective activity of kinsenoside from Anoectochilus formosanus.
    Phytotherapy research : PTR, 2007, Volume: 21, Issue:1

    Topics: 4-Butyrolactone; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Lethal Dose 50; Male; Mice; Monosaccharides; Orchidaceae; Phytotherapy; Plant Extracts; Protective Agents

2007